Does perioperative immunonutrition reduce postoperative complications in patients with gastrointestinal cancer undergoing operations?

Nutrition Reviews

Volumn 62, Issue 11, 2004, Pages 443-447

  Moskovitz, David N ^a   Kim, Young In ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; OMEGA 3 FATTY ACID; RNA;

CANCER SURGERY; CLINICAL TRIAL; CRITICAL ILLNESS; DIET THERAPY; DIGESTIVE SYSTEM CANCER; ELECTIVE SURGERY; HISTOPATHOLOGY; HUMAN; IMMUNOMODULATION; IMMUNONUTRITION; ITALY; META ANALYSIS; NUTRITION; NUTRITIONAL SUPPORT; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; SHORT SURVEY; SYSTEMATIC REVIEW; WEIGHT REDUCTION;

CACHEXIA; DIETARY SUPPLEMENTS; ENTERAL NUTRITION; GASTROINTESTINAL NEOPLASMS; HUMANS; IMMUNOTHERAPY; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; TREATMENT OUTCOME;

EID: 9344242395     PISSN: 00296643     EISSN: None     Source Type: Journal    
DOI: 10.1301/nr.2004.nov.443-447     Document Type: Short Survey

References (25)

1. Delafuente JC. Nutrients and immune responses. Rheum Dis Clin North Am. 1991;17:203-212.
2. Heys SD, Walker LG, Smith I, Eremin O. Enteral nutritional supplementation with key nutrients in patients with critical illness and cancer: a meta-analysis of randomized controlled clinical trials. Ann Surg. 1999;229:467-477.
3. Beale RJ, Bryg DJ, Bihari DJ. Immunonutrition in the critically ill: a systematic review of clinical outcome. Crit Care Med. 1999;27:2799-2805.
4. Heyland DK, Novak F, Drover JW, Jain M, Su X, Suchner U. Should immunonutriton become routine in critically ill patients? A systematic review of the evidence. JAMA. 2001;286:944-953.
5. Mutlu EA, Mobarhan S. Nutrition in the care of the cancer patient. Nutr Clin Care. 2000;3:3-23.
6. Kovacevic Z, McGivan JD. Mitochondrial metabolism of glutamine and glutamate and its physiological significance. Physiol Rev. 1983;63:547-605.
7. Field CJ, Johnson I, Pratt VC. Glutamine and arginine: immunonutrients for improved health. Med Sci Sports Exerc. 2000;32 (suppl 7):S377-S388.
8. Newsholme P. Why is L-glutamine metabolism important to cells of the immune system in health, postinjury, surgery or infection? J Nutr. 2001;131 (suppl 9):2515S-2524S.
9. Griffiths RD. The evidence for glutamine use in the critically-ill. Proc Nutr Soc. 2001;60:403-410.
10. Daly JM, Reynolds J, Thom A, et al. Immune and metabolic effects of arginine in the surgical patient. Ann Surg. 1998;208:512-523.
11. Brittenden J, Heys SD, Ross J, Park KG, Eremin O. Natural cytotoxicity in breast cancer patients receiving neoadjuvant chemotherapy: effects of L-arginine supplementation. Eur J Surg Oncol. 1994;20:467-472.
12. Bruce DM, Heys SD, Segar A, et al. Enhancement of tumor infiltrating lymphocytes in human tumors by dietary supplementation with L-arginine. Br J Surg. 1995;82:703.
13. Brittenden J, Heys SD, Eremin O. L-arginine and malignant disease: a potential therapeutic role? Eur J Surg Oncol. 1994;20:189-192.
14. Caparros T, Lopez J, Grau T. Early enteral nutrition in critically ill patients with a high-protein diet enriched with arginine, fiber, and antioxidants compared with a standard high-protein diet. The effect in nosocomial infections and outcome. JPEN J Parenter Enter Nutr. 2001;25:299-309.
15. Gottschlich MM, Jenkins M, Warden GD, et al. Differential effects of three enteral dietary regimens on selected outcome variables in burn patients. JPEN. 1990;14:225-236.
16. Calder PC. Dietary fatty acids and the immune system. Nutr Rev. 1998;56 (1 part 2):S70-S83.
17. Blok WL, Katan MB, van der Meer JW. Modulation of inflammation and cytokine production by dietary (n-3) fatty acids. J Nutr. 1996;126:1515-1533.
18. Gogos CA, Ginopoulos P, Salsa B, Apostolidou E, Zoumbos NC, Kalfaretzos F. Dietary omega-3 poly-unsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: a randomized control trial. Cancer. 1998;82:395-402.
19. Youn JK, Kim BS, Min JS, et al. Adjuvant treatment of operable stomach cancer with polyadenylic poly-uridylic acid in addition to chemotherapeutic agents: a preliminary report. Int J Immunopharmacol. 1990;12:289-295.
20. Lacour J, Laplanche A, Delozier T, et al. Polyadenylic-polyuridylic acid plus locoregional and pelvic tariotherapy versus chemotherapy with CMF as adjuvants in operable breast cancer. A 6 1/2 year follow-up analysis of a randomized trial of the French Federation of Cancer Centers (F.F.C.C.). Breast Cancer Res Treat. 1991;19:15-21.
21. Klein S, Kinney J, Jeejeebhoy K, et al. Nutrition support in clinical practice: review of published data and recommendations for future research directions. Summary of a conference sponsored by the National Institutes of Health, American Society for Parenteral and Enteral Nutrition, and American Society for Clinical Nutrition. Am J Clin Nutr. 1997;66:683-706.
22. Fietkau R, Iro H, Sailer D, Sauer R. Percutaneous endoscopically guided gastrostomy in patients with head and neck cancer. Recent Results Cancer Res. 1991;121:269-282.
23. Klein S, Koretz RL. Nutrition support in patients with cancer: what do the data really show? Nutr Clin Pract. 1994;9:91-100.
24. Bower RH, Cerra FB, Bershadsky B, et al. Early enteral administration of a formula (Impact) supplemented with arginine, nucleotides, and fish oil in intensive care unit patients: results of a multicenter, prospective, randomized, clinical trial. Crit Care Med. 1995;23:436-449.
25. Gianotti L, Braga M, Nespoli L, Radaelli G, Beneduce A, Di Carlo V. A randomized controlled trial of preoperative oral supplementation with a specialized diet in patients with gastrointestinal cancer. Gastroenterology. 2002;122:1763-1770.